<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211117053087N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-19</date_registration>
      <primary_sponsor>Alborz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of single oral dose vitamin D on left ventricular remodelling in patients with acute anterior left ventricular infarction referred to Shahid Rajaei Hospital and comparison with randomized clinical trial control group IRCT</public_title>
      <acronym></acronym>
      <scientific_title>The effect of single oral dose vitamin D on left ventricular remodelling in patients with acute anterior left ventricular infarction referred to Shahid Rajaei Hospital and comparison with randomized clinical trial control group IRCTcular</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-01-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>140</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60216</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be performed by block randomization method with heterogeneous blocks 2, 4, and 6 to hide the allocation order. The randomization list will be prepared in advance using the software available on the relevant, reputable website. (https://www.sealedenvelope.com/simple-randomiser/v1/lists). After the physician (responsible researcher) determines that the patient is eligible, the researcher, who has the confidential randomization list, will be contacted to assign the patient to one of the two groups, Blinding description: Both the data analyzer and the sample collector are kept blind. These people do not know which study group the questionnaire they fill out with patients belongs to. Intervention or control. Analysts also analyze raw information in which it is not clear whether this information is for the control group or the intervention.</study_design>
      <phase>3</phase>
      <hc_freetext>Patients with acute left ventricular anterior infarction who are candidates for angioplasty.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: People in the intervention group are patients with acute anterior infarction of the left ventricle who are referred to Rajai Hospital in Karaj. If vitamin D is below 30 in the blood, they will be given a bolus dose of 50,000 units of vitamin D. And it is recommended to take one pill a week of vitamin D. Intervention 2: Control group: receives routine treatments that patients with acute anterior infarction receive and there is no change in the treatment process.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is As a medical student, which is my dissertation, I leave the decision in this regard to the faculty and the research committee of the faculty.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Basavand</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Alborz Ubiversity of Medical Science</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>0000000</zip>
        <telephone>+98 919 772 3022</telephone>
        <email>ffatemehhbsv@gmail.com</email>
        <affiliation>Karaj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatmeh Basavand</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Alborz University of Medical Science/ West Bouali/Nabbovat Boulvard</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>0000</zip>
        <telephone>+98 26 3255 8921</telephone>
        <email>ffatemehhbsv@gmail.com</email>
        <affiliation>Karaj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>age between 40_85
patients with Anterior  infarction less than 12 hours after the onset of symptoms
Patient informed consent to participate in the research project</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>85 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>history of infarction
history of abnormal LVEF
history of cardiomyopathy
History of taking vitamin D supplements
Moderate to severe valvular disease
Calcium above 10.5
Allergy to vitamin D supplementation
Individuals with BMI above 30 m2 / kg
People who are not expected to stay in the study
People with any life-threatening medical conditions
renal failure
liver failure
People with a history of any known cancer
Rheumatological and immunological diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: People in the intervention group are patients with acute anterior infarction of the left ventricle who are referred to Rajai Hospital in Karaj. If vitamin D is below 30 in the blood, they will be given a bolus dose of 50,000 units of vitamin D. And it is recommended to take one pill a week of vitamin D.</i_keyword>
      <i_keyword>Control group: receives routine treatments that patients with acute anterior infarction receive and there is no change in the treatment process.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>LV EF. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>LVESDI. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>LVESVI. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>LVEDVI. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>LVEDDI. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>Diastolic function. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>LV MASS. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>Sphercity Index. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>GLS. Timepoint: At the beginning of the study and two months later. Method of measurement: ECO TDI.</prim_outcome>
      <prim_outcome>Troponin. Timepoint: At the beginning of the study and two months later. Method of measurement: Blood test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Alborz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-20</approval_date>
        <contact_name>Ethics committee of Alborz University of Medical Science</contact_name>
        <contact_address>Sara Dormitory /The entrance of Honar pool/, Nabout Boulevard,  /Karaj Karaj Alborz Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
